Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
Manufacturing
Return to: PBR Home | Production & Manufacturing | Manufacturing

Manufacturing

SK Capital to acquire Perrigo’s Israeli API business By PBR Staff Writer
New York-based private investment firm SK Capital has agreed to acquire Perrigo API, the active pharmaceutical ingredients (API) business of Perrigo Company in Israel, for $110m in an all-cash deal.
Production & Manufacturing > Manufacturing > News
Celgene, Sutro revise 2014 immuno-oncology collaboration By PBR Staff Writer
Celgene has revised the terms of its immuno-oncology collaboration with Sutro Biopharma, which was established in 2014.
Production & Manufacturing > Manufacturing > News Roche agrees to sell eczema drug rights to Dermira By PBR Staff Writer
Dermira has signed a licensing agreement with Roche to secure exclusive rights to lebrikizumab, a monoclonal antibody targeting interleukin 13 (IL-13), for atopic dermatitis and all other indications.
Production & Manufacturing > Manufacturing > News
See more Manufacturing news

Latest Manufacturing News and Insight

View all Manufacturing news or find news targeted to your interests
Roche agrees to sell eczema drug rights to Dermira
By PBR Staff Writer
Dermira has signed a licensing agreement with Roche to secure exclusive rights to lebrikizumab, a monoclonal antibody targeting interleukin 13 (IL-13), for atopic dermatitis and all other indications.
Production & Manufacturing > Manufacturing > News
Kite Pharma seeks European approval for Axicabtagene Ciloleucel
Kite Pharma has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for axicabtagene ciloleucel as a treatment for patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL), transformed follicular lymphoma (TFL), and primary mediastinal B-cell lymphoma (PMBCL) who are not eligible for autologous stem cell transplant.
Production & Manufacturing > Manufacturing > News
Tosoh Bioscience: New High Capacity TOYOPEARL® rProtein L Resin
High capacity chromatography resin for the capture of antibodies and antibody fragments.
Production & Manufacturing > Manufacturing > Press Releases
Celgene to pay $280m to settle False Claims Act litigation in US
Celgene has reached a civil settlement with Relator Brown, the Department of Justice, 28 States, the District of Columbia, and the City of Chicago to resolve the previously disclosed False Claims Act litigation pending in the United States District Court for the Central District of California.
Production & Manufacturing > Manufacturing > News
View all Manufacturing news or find news targeted to your interests